on NFL BIOSCIENCES (EPA:ALNFL)
Half-yearly report on the NFL BIOSCIENCES liquidity contract
NFL BIOSCIENCES, a biopharmaceutical company, has released its half-year results for 2025 regarding the liquidity contract entrusted to Invest Securities. As of June 30, 2025, the liquidity account held 123,648 NFL BIOSCIENCES shares and €123,585.44.
During the half-year, transactions included the purchase of 177,634 shares for 262,674.40 euros through 808 operations, while 111,463 shares were sold for 183,167.73 euros in 738 transactions.
Compared to December 31, 2024, the available resources were then 57,477 securities and 201,346.52 euros. At the initialization of the liquidity contract, no securities but 200,000 euros in cash were allocated.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NFL BIOSCIENCES news